Dr. Cabanillas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161- Is this information wrong?
Education & Training
Baylor College of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 2007 - 2009
University of Texas Health Science Center at HoustonResidency, Internal Medicine, 1998 - 2001
University of Puerto Rico School of MedicineClass of 1998
Certifications & Licensure
FL State Medical License 2021 - Present
WA State Medical License 2022 - 2026
TN State Medical License 2022 - 2026
TX State Medical License 2001 - 2024
OK State Medical License 2020 - 2024
AZ State Medical License 2022 - 2024
AL State Medical License 2023 - 2024- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
- Join now to see all
Clinical Trials
- A Study of Actonel for the Prevention of Bone Loss Start of enrollment: 2004 Feb 01
- The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer Start of enrollment: 2012 Nov 01
- Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer Start of enrollment: 2013 May 08
- Join now to see all
Publications & Presentations
PubMed
- Next-Generation Sequencing in Sporadic Medullary Thyroid Cancer Patients: Mutation Profile and Disease Aggressiveness.Yi-Ju Chiang, Vijaykumar R Holla, Mark E Zafereo, Aditya S Shirali, Mimi I Hu, Paul H Graham, Sarah B Fisher, Julie Ann Sosa, Nancy Perrier, Spandana Brown, Ramona Dad...> ;Journal of the Endocrine Society. 2024 Apr 6
- RAF inhibitor re-challenge therapy in BRAF-aberrant pan-cancers: the RE-RAFFLE study.Jason Roszik, Carmelia Maria Noia Barretto, Erick Campbell, Amber M Johnson, Isabella C Glitza Oliva, Blessie Elizabeth Nelson, Jibran Ahmed, Mirella Nardo, Sarina A P...> ;Molecular Cancer. 2024 Mar 26
- Adaptive Darwinian off-target resistance mechanisms to selective RET inhibition in RET driven cancer.Vivek Subbiah, Mohamed A Gouda, J Bryan Iorgulescu, Ramona Dadu, Keyur Patel, Steven Sherman, Maria Cabanillas, Mimi Hu, Luz E Castellanos, Behrang Amini, Funda Meric-...> ;NPJ Precision Oncology. 2024 Mar 4
- Join now to see all
Journal Articles
- Efficacy of Selpercatinib in RET-Altered Thyroid CancersLori J Wirth, Jochen Lorch, Francis Worden, Marcia Brose, Taofeek K Owonikoko, Mark E Burkard, Todd M Bauer, Viola W Zhu, Nehal Lakhani, Victor Moreno, Manisha H Shah,..., The New England Journal of Medicine
- Targeted Therapy in Advanced Thyroid Cancer to Resensitize Tumors to Radioactive IodineThinh Vu, Naifa L Busaidy, Maria E Cabanillas, Steven G Waguespack, Steven I Sherman, Mark Zafereo, The Journal of Clinical Endocrinology and Metabolism
- Selective RET Kinase Inhibition for Patients with RET-Altered CancersL J Wirth, N L Busaidy, M E Cabanillas, Annals of Oncology
Lectures
- Advanced Thyroid Cancers: New Insights and TreatmentsENDO 2019 - New Orleans, LA - 3/25/2019
- From Thyroid Nodules to Thyroid Cancer: Diagnosis and TreatmentENDO 2019 - New Orleans, LA - 3/25/2019
- New Medical Options for the Treatment of Advanced Thyroid CancerENDO 2019 - New Orleans, LA - 3/24/2019
Authored Content
- Efficacy of Selpercatinib in RET-Altered Thyroid CancersAugust 2020
Press Mentions
His Thyroid Cancer Was Too Rare for Doctors to Treat. After a Trial, Woodlands Man Now Cancer-FreeDecember 14th, 2022- Progress in Treating Medullary Thyroid CancerSeptember 20th, 2020
- Lung Cancer Trial of RET Inhibitor Selpercatinib Achieves Durable Responses in Majority of Patients with RET Gene FusionsAugust 26th, 2020
- Join now to see all
Professional Memberships
- Member
- Member
Hospital Affiliations
University of Texas M.D. Anderson Cancer CenterHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
